SF7a-1 Use of Daclizumab in Induction Immunosuppressive Therapy in Clinical Intestinal Transplantation

スポンサーリンク

概要

著者

関連論文

Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma : Prognostic factors and unique toxicity profile
Thalidomide-Induced Severe Neutropenia during Treatment of Multiple Myeloma
Recurrence of Autoimmune Disease after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
Thalidomide for the Treatment of Refractory Multiple Myeloma : Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome
Elevated Level of Plasma Basic Fibroblast Growth Factor in Multiple Myeloma Correlates with Increased Disease Activity
Immunization with ACE (Angiotensin Converting Enzyme) Develops Diabetic Changes in the Kidney and Retina in Diabetogenic Rats
Circulating endogenous thrombopoietin, interleukin-3, interleukin-6 and interleukin-11 levels in patients undergoing allogeneic bone marrow transplantation
SF7a-1 Use of Daclizumab in Induction Immunosuppressive Therapy in Clinical Intestinal Transplantation
O-192 Liver transplantation for patients with hepatic malignancies.
O-191 Clinical Outcomes of Intestinal Transplantation at the University of Miami.
Improved Outcome In Liver Transplantation For Hepatitis B Under Lamivudine Treatment
The Higher Immunoreactivity to ACE (Angiotensin Converting Enzyme) in Patients with Type 2 Diabetes Mellitus than in Non-Diabetic Individuals
Effects and serum levels of thrombopoietin in a case of chronic thrombocytopenia with achondroplasia
Dexamethasone Suppressibility of Plasma Pregnenolone (3β-Hydroxy-5-pregnen-20-one) in Normal Men
A Radioimmunoassay for Human Plasma Corticosterone

もっと見る

スポンサーリンク